Elevation Oncology Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition

Prioritizing the development of EO-3021, a potential best-in-class ADC targeting Claudin18.2, and additional pipeline programs including those through its...

Related Keywords

China ,Shawnm Leland ,Joseph Ferra ,Shawn Leland ,Valerie Malyvanh Jansen ,Josephj Ferra ,David Dornan ,Exchange Commission ,Prnewswire Elevation Oncology Inc ,Group Limited ,Elevation Oncology Inc ,Corporate Communications Investor Relations ,Caris Life Sciences ,Nasdaq ,Caris Life ,Chief Executive Officer ,Interim Chief Executive ,Chief Financial Officer ,Elevation Oncology ,Chief Medical Officer ,Chief Scientific ,Interim Chief Executive Officer ,Steve Elms ,Investigational New Drug ,Pipeline Programs ,Chief Financial ,Cash Runway ,Looking Statements ,Private Securities Litigation Reform Act ,Although Elevation Oncology ,Oncology Investor ,Corporate Communications ,